Archives

by in
Entry Author Date Location
Immune Design, NY Non-Profits Team Up to Boost Cancer Drugs 06/12/13 Seattle
Agios Files For IPO With Plans to Raise $86M 06/11/13 Boston
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
CytomX Snags $25M From Pfizer to Make Souped-Up Antibodies 06/06/13 San Francisco
ASCO Wrap-Up: Cancer News from the West Coast 06/04/13 National
Biodesix’s VeriStrat Test for Cancer Treatment Passes Phase 3 Trial 06/03/13 Boulder/Denver
Merck Joins Bristol, Genentech in Great Cancer Immunotherapy Race 06/02/13 New York
Plexxikon Leadership Duo, Peter Hirth and Kathy Glaub, Exit Daiichi 05/31/13 San Francisco
Oncothyreon Nabs $10M, Pays $10M, For Array Biopharma Cancer Drug 05/30/13 Seattle
UT Horizon Fund Aims to Build, and Capture, Value from Its Startups 05/21/13 Texas
Genentech Follows Fast at ASCO as Cancer Immunotherapy Picks Up 05/15/13 San Francisco
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study 05/15/13 San Francisco
Ensysce’s Bet: Combining Two Risky Drug Technologies That Add Up 05/09/13 Texas
San Diego Life Sciences Roundup: Topera, Afraxis, Trovagene, & More 05/03/13 San Diego
Aveo’s Stock Plunges As Day of Reckoning Nears For Cancer Drug 04/30/13 Boston
Meet Ben Fidler, Xconomy’s New East Coast Biotech Editor 04/15/13 New York
Live! Anderson & Ferrara Headline Rock Stars of Innovation Summit 03/26/13 San Diego
Third Rock Stocks Up With $516M New Fund, Looks to Start 16 Cos 03/25/13 Boston
Biotech VCs Aren’t Lemmings Anymore. They’re Lone Rangers 03/25/13 National
Memorial Sloan-Kettering and Eureka Go After ‘Undruggable’ Targets 03/21/13 New York
AstraZeneca Shells Out $240M Upfront For Moderna mRNA Drugs 03/21/13 Boston
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Cerulean Pharma Arrives at Turning Point With Cancer Drug 03/06/13 Boston
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
East Coast Life Sciences Roundup: IBM, ImmunoGen, Breakthrough Prize, & More 02/22/13 New York
Genentech, ImmunoGen Win FDA OK for Souped-Up Breast Cancer Drug 02/22/13 San Francisco
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
San Diego Life Sciences Roundup: RQx Pharma, Elcelyx, Lux, & More 02/15/13 San Diego
Third Rock’s Latest, Jounce, Grabs $47M For Cancer Immunotherapy 02/14/13 Boston
In VC ‘Hat Trick’ for San Diego’s Avalon, RQx Inks Genentech Deal 02/12/13 San Diego
Page 1 of 13 next page »

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.